C. Hasan

发表

The beta2-microglobulin/cystatin C ratio--a potential marker of post-transplant lymphoproliferative disease.

B. Stoffel‐Wagner, M. Lentze, G. Offner, 2002, Clinical nephrology.

Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology

G. Henze, P. H. Driever, R. Hartmann, 2006, Supportive Care in Cancer.

Treatment of Relapsed AML of Childhood with Daunoxome-FLAG (Liposomal Daunorubicin, Fludarabine, High-Dose Cytarabine and G-CSF)

U. Bode, G. Fleischhack, N. Graf, 2003 .

Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer.

A. Simon, U. Bode, G. Fleischhack, 2001, The Journal of antimicrobial chemotherapy.

Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C‐reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II

U. Bode, G. Fleischhack, C. Hasan, 2000, British journal of haematology.

Cyanotic Raynaud's phenomenon with conventional but not with liposomal amphotericin B: three case reports

U. Bode, G. Fleischhack, B. Zernikow, 1997, Mycoses.

High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma

B. Hero, A. Schulz, C. Niemeyer, 2003, Bone Marrow Transplantation.

Diffuse hemangiolymphangiomatosis in an infant.

A. Simon, U. Bode, G. Fleischhack, 2002, Medical and pediatric oncology.

[IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].

U. Bode, G. Fleischhack, N. Graf, 1996, Klinische Padiatrie.

Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia.

S. Engelhart, A. Simon, U. Bode, 2006, International journal of antimicrobial agents.

Influence of Prolonged Use of Intravenous Administration Sets in Paediatric Cancer Patients on CVAD-related Bloodstream Infection Rates and Hospital Resources

A. Simon, U. Bode, G. Fleischhack, 2006, Infection.

Identification of a novel mutation in the coding region of the grey‐lethal gene OSTM1 in human malignant infantile osteopetrosis

A. Ramírez, U. Kornak, U. Bode, 2004, Human mutation.

Norovirus outbreak in a pediatric oncology unit

S. Engelhart, A. Simon, U. Bode, 2006, Scandinavian journal of gastroenterology.

Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure

G. Henze, U. Bode, G. Fleischhack, 2005, British Journal of Cancer.

Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants

A. Glasmacher, A. Simon, U. Bode, 2007, Supportive Care in Cancer.

Surveillance for Nosocomial and Central Line-Related Infections Among Pediatric Hematology-Oncology Patients

S. Engelhart, A. Simon, U. Bode, 2000, Infection Control & Hospital Epidemiology.

Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours

U. Jaehde, S. Reif, U. Bode, 2001, British Journal of Cancer.

Pancreatic toxicity after liposomal amphotericin B 

U. Bode, G. Fleischhack, C. Hasan, 2002, Mycoses.

Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients

U. Bode, G. Fleischhack, W. Havers, 2001, Supportive Care in Cancer.

Immature Gastric Teratoma of the Lesser Curvature in a Male Infant

U. Bode, G. Fleischhack, B. Utsch, 2001, Journal of pediatric gastroenterology and nutrition.

The role of complete surgical resection in stage IV neuroblastoma

U. Bode, G. Fleischhack, P. Bastian, 2004, World Journal of Urology.

INTRACRANIAL MANIFESTATION OF OSTEOSARCOMA

T. Kral, U. Bode, S. Hettmer, 2002, Pediatric hematology and oncology.

Oncological Management of Pediatric Cancer Patients Belonging to Jehovah’s Witnesses: A Two-Institutional Experience Report

C. Kramm, U. Bode, R. Wessalowski, 2004, Oncology Research and Treatment.

Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis.

A. Schulz, W. Friedrich, U. Kornak, 2000, Human molecular genetics.

High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma

B. Hero, A. Schulz, C. Niemeyer, 2002, Bone Marrow Transplantation.

Homozygous α-thalassaemia and hypospadias – common aetiology or incidental association?

U. Bode, R. Brenner, N. Albers, 1999, European Journal of Pediatrics.

111In-Pentetreotide scintigraphy in medulloblastoma: A comparison with magnetic resonance imaging

U. Bode, G. Lutterbey, S. Ezziddin, 2007, Acta oncologica.

Nephrotic syndrome as paraneoplastic syndrome of Hodgkin Disease

U. Bode, G. Fleischhack, B. Utsch, 1999, European Journal of Pediatrics.

Procalcitonin—a sensitive inflammation marker of febrile episodes in neutropenic children with cancer

U. Bode, G. Fleischhack, C. Hasan, 2000, Intensive Care Medicine.

Procalcitonin – a sensitive inflammation marker of febrile episodes in neutropenic children with cancer

U. Bode, G. Fleischhack, C. Hasan, 2000, Intensive Care Medicine.

Reply to de bont Et al

U. Bode, G. Fleischhack, C. Hasan, 2001 .

Recancostat compositum® therapy does not prevent tumor progression in young cancer patients

U. Bode, G. Fleischhack, C. Hasan, 1999, Klinische Padiatrie.

ACUTE LIVER DISEASE AND APLASTIC ANEMIA ASSOCIATED WITH THE PERSISTENCE OF B19 DNA IN LIVER AND BONE MARROW

U. Bode, C. Dame, A. Eis-Hübinger, 2002, Pediatric pathology & molecular medicine.

IDA‐FLAG (idarubicin, fludarabine, cytarabine, G‐CSF), an effective remission‐induction therapy for poor‐prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial

C. Hasan, Hasan, Fleischhack, 1998, British journal of haematology.